Education
About Us
Working with TipRanks
Follow Us
Supriya Lifescience Limited (IN:SUPRIYA)
:SUPRIYA
Total Valuation
Supriya Lifescience Limited has a market cap or net worth of ₹56.41B. The enterprise value is ₹44.54B.
Market Cap₹56.41B
Enterprise Value₹44.54B
Share Statistics
Supriya Lifescience Limited has 80,482,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,482,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Supriya Lifescience Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 17.64%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)17.64%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee15.55M
Profits Per Employee4.20M
Employee Count448
Asset Turnover0.63
Inventory Turnover2.64
Valuation Ratios
The current PE Ratio of Supriya Lifescience Limited is 31.7. Supriya Lifescience Limited’s PEG ratio is 0.54.
PE Ratio31.7
PS Ratio8.46
PB Ratio5.91
Price to Fair Value5.91
Price to FCF578.14
Price to Operating Cash Flow0.00
PEG Ratio0.54
Income Statement
In the last 12 months, Supriya Lifescience Limited had revenue of 6.96B and earned 1.88B in profits. Earnings per share was 23.35.
Revenue6.96B
Gross Profit3.84B
Operating Income2.40B
Pretax Income2.48B
Net Income1.88B
EBITDA2.71B
Earnings Per Share (EPS)23.35
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Supriya Lifescience Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.14%
Dividend Per Share₹1
Dividend Yield0.14%
Payout Ratio5.00%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.08
52-Week Price Change28.55%
50-Day Moving Average674.73
200-Day Moving Average690.78
Relative Strength Index (RSI)54.64
Average Volume (3m)14.59K
Important Dates
Supriya Lifescience Limited upcoming earnings date is Nov 5, 2025, Before Open (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend DateSep 04, 2025
Financial Position
Supriya Lifescience Limited as a current ratio of 5.32, with Debt / Equity ratio of 0.54%
Current Ratio5.32
Quick Ratio3.88
Debt to Market Cap<0.01
Net Debt to EBITDA-0.27
Interest Coverage Ratio142.56
Taxes
In the past 12 months, Supriya Lifescience Limited has paid 605.23M in taxes.
Income Tax605.23M
Effective Tax Rate0.24
Enterprise Valuation
Supriya Lifescience Limited EV to EBITDA ratio is 21.50, with an EV/FCF ratio of 570.90.
EV to Sales8.35
EV to EBITDA21.50
EV to Free Cash Flow570.90
EV to Operating Cash Flow33.71
Balance Sheet
Supriya Lifescience Limited has ₹843.14M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹843.14M billion.
Cash & Marketable Securities₹843.14M
Total Debt₹0.00
Net Cash₹843.14M
Net Cash Per Share₹10.48
Tangible Book Value Per Share₹123.83
Margins
Gross margin is 63.90%, with operating margin of 34.51%, and net profit margin of 26.99%.
Gross Margin63.90%
Operating Margin34.51%
Pretax Margin35.68%
Net Profit Margin26.99%
EBITDA Margin38.85%
EBIT Margin35.92%
Analyst Forecast
The average price target for Supriya Lifescience Limited is ₹718.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹718.00
Price Target Upside2.43% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast13.68%
EPS Growth Forecast31.69%